[CLSTR]
< Back to all clusters
[HEALTH] · United States, India, Serbia · 3 sources

started · updated

Global developments in cancer treatment and medication costs

cancer immunotherapy CAR-T therapy drug pricing oncology medications healthcare policy

Researchers at the Keck School of Medicine at the University of Southern California (USC) have developed a new method to create a universal source of immune cells modified to target tumor tissues. This breakthrough aims to address the limitations of current CAR-T cell therapy, which is often hindered by high costs, long preparation times, and the limited availability of a patient's own T-cells.

In India, the government is set to reduce the prices of 137 oncology drugs starting next month. Following a Supreme Court ruling that condemned excessive profit margins by hospitals and pharmacies as “extortion,” the government will cap trade margins on these medications at 30 percent. Some therapies may see price reductions of up to 70 percent, potentially saving patients approximately 19.9 million British pounds annually.

In Serbia, the state has implemented measures to lower the cost of 18 prescription medications, specifically targeting anticoagulants and heart failure treatments. The government is covering up to 70 percent of the cost for anticoagulants and 50 percent for heart failure medications, supported by a budget allocation of 3.7 billion dinars.

Entities

Keck School of Medicine of USC · Sarojam Radhakrishnan · Serbia · Supreme Court of India · University of Southern California

Claims

What the coverage asserts, and how many sources carry each claim.

  • [○ 1 SOURCE] Serbia's state is covering up to 70 percent of the cost for 16 types of anticoagulants. www.kurir.rs
  • [○ 1 SOURCE] Scientists at USC developed a method to create a universal source of immune cells for tumor targeting. metro-portal.hr
  • [○ 1 SOURCE] India will reduce prices for 137 oncology drugs starting next month. www.dalmacijadanas.hr
  • [○ 1 SOURCE] The Indian government will cap trade margins on 137 cancer drugs at 30 percent. www.dalmacijadanas.hr
  • [○ 1 SOURCE] The Serbian government allocated 3.7 billion dinars for medication cost coverage. www.kurir.rs
  • [○ 1 SOURCE] Some cancer drug prices in India could drop by up to 70 percent. www.dalmacijadanas.hr
  • [○ 1 SOURCE] Serbia is covering 50 percent of the cost for two heart failure medications. www.kurir.rs

Sources

Revolucionarno otkriće u liječenju raka: novi T-stanični imunološki proboj [metro-portal.hr]
Indija drastično snižava cijene 137 lijekova za oboljele od raka, neki će pojeftiniti i do 70 posto [www.dalmacijadanas.hr]
Za ove lekove sada se plaća mnogo manje! Detaljni spisak medikamenata koji su pojeftinili [www.kurir.rs]